Literature DB >> 29890087

Cigarette smoke modifies and inactivates SPLUNC1, leading to airway dehydration.

Patrick J Moore1, Boris Reidel1, Arunava Ghosh1, Juliana Sesma2, Mehmet Kesimer1, Robert Tarran1,3.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a growing cause of morbidity and mortality worldwide. Cigarette smoke (CS) exposure, a major cause of COPD, dysregulates airway epithelial ion transport and diminishes airway surface liquid (ASL) volume. Short palate lung and nasal epithelial clone 1 (SPLUNC1) is secreted into the airway lumen where it maintains airway hydration via interactions with the epithelial Na+ channel (ENaC). Although ASL hydration is dysregulated in CS-exposed/COPD airways, effects of CS on SPLUNC1 have not been elucidated. We hypothesized that CS alters SPLUNC1 activity, therefore contributing to ASL dehydration. CS exposure caused irreversible SPLUNC1 aggregation and prevented SPLUNC1 from internalizing ENaC and maintaining ASL hydration. Proteomic analysis revealed αβ-unsaturated aldehyde modifications to SPLUNC1's cysteine residues. Removal of these cysteines prevented SPLUNC1 from regulating ENaC/ASL volume. In contrast, SPX-101, a peptide mimetic of natural SPLUNC1, that internalizes ENaC, but does not contain cysteines was unaffected by CS. SPX-101 increased ASL hydration and attenuated ENaC activity in airway cultures after CS exposure and prolonged survival in a chronic airway disease model. These findings suggest that the CS-induced defects in SPLUNC1 can be circumvented, thus making SPX-101 a novel candidate for the treatment of mucus dehydration in COPD. -Moore, P. J., Reidel, B., Ghosh, A., Sesma, J., Kesimer, M., Tarran, R. Cigarette smoke modifies and inactivates SPLUNC1, leading to airway dehydration.

Entities:  

Keywords:  BPIFA1; COPD; ENaC; airway surface liquid; αβ-unsaturated aldehydes

Year:  2018        PMID: 29890087      PMCID: PMC6219833          DOI: 10.1096/fj.201800345R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  54 in total

1.  Adverse Outcomes Associated with Cigarette Smoke Radicals Related to Damage to Protein-disulfide Isomerase.

Authors:  Harshavardhan Kenche; Zhi-Wei Ye; Kokilavani Vedagiri; Dylan M Richards; Xing-Huang Gao; Kenneth D Tew; Danyelle M Townsend; Anna Blumental-Perry
Journal:  J Biol Chem       Date:  2016-01-04       Impact factor: 5.157

2.  A study of reactive oxygen species in mainstream of cigarette.

Authors:  M-F Huang; W-L Lin; Y-C Ma
Journal:  Indoor Air       Date:  2005-04       Impact factor: 5.770

3.  Normal alveolar epithelial lining fluid contains high levels of glutathione.

Authors:  A M Cantin; S L North; R C Hubbard; R G Crystal
Journal:  J Appl Physiol (1985)       Date:  1987-07

4.  Roflumilast combined with adenosine increases mucosal hydration in human airway epithelial cultures after cigarette smoke exposure.

Authors:  Jean Tyrrell; Xiaozhong Qian; Jose Freire; Robert Tarran
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-03-20       Impact factor: 5.464

5.  Regional impairment of mucociliary clearance in chronic obstructive pulmonary disease.

Authors:  G C Smaldone; W M Foster; T G O'Riordan; M S Messina; R J Perry; E G Langenback
Journal:  Chest       Date:  1993-05       Impact factor: 9.410

6.  SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage.

Authors:  Agustin Garcia-Caballero; Julia E Rasmussen; Erol Gaillard; Michael J Watson; John C Olsen; Scott H Donaldson; M Jackson Stutts; Robert Tarran
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-18       Impact factor: 11.205

7.  Human neutrophil elastase degrades SPLUNC1 and impairs airway epithelial defense against bacteria.

Authors:  Di Jiang; Sally E Wenzel; Qun Wu; Russell P Bowler; Christina Schnell; Hong Wei Chu
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

8.  The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition.

Authors:  R Tarran; B R Grubb; J T Gatzy; C W Davis; R C Boucher
Journal:  J Gen Physiol       Date:  2001-08       Impact factor: 4.086

9.  Structural Features Essential to the Antimicrobial Functions of Human SPLUNC1.

Authors:  William G Walton; Saira Ahmad; Michael S Little; Christine S K Kim; Jean Tyrrell; Qiao Lin; Y Peter Di; Robert Tarran; Matthew R Redinbo
Journal:  Biochemistry       Date:  2016-05-17       Impact factor: 3.162

10.  Excess Secretion of Gel-Forming Mucins and Associated Innate Defense Proteins with Defective Mucin Un-Packaging Underpin Gallbladder Mucocele Formation in Dogs.

Authors:  Mehmet Kesimer; John Cullen; Rui Cao; Giorgia Radicioni; Kyle G Mathews; Gabriela Seiler; Jody L Gookin
Journal:  PLoS One       Date:  2015-09-28       Impact factor: 3.240

View more
  5 in total

Review 1.  Origin and Fate of Acrolein in Foods.

Authors:  Kaiyu Jiang; Caihuan Huang; Fu Liu; Jie Zheng; Juanying Ou; Danyue Zhao; Shiyi Ou
Journal:  Foods       Date:  2022-07-03

Review 2.  E-Cigarettes and Cardiopulmonary Health.

Authors:  Robert Tarran; R Graham Barr; Neal L Benowitz; Aruni Bhatnagar; Hong W Chu; Pamela Dalton; Claire M Doerschuk; M Bradley Drummond; Diane R Gold; Maciej L Goniewicz; Eric R Gross; Nadia N Hansel; Philip K Hopke; Robert A Kloner; Vladimir B Mikheev; Evan W Neczypor; Kent E Pinkerton; Lisa Postow; Irfan Rahman; Jonathan M Samet; Matthias Salathe; Catherine M Stoney; Philip S Tsao; Rachel Widome; Tian Xia; DaLiao Xiao; Loren E Wold
Journal:  Function (Oxf)       Date:  2021-02-08

3.  SPLUNC1: a novel marker of cystic fibrosis exacerbations.

Authors:  Sara Khanal; Megan Webster; Naiqian Niu; Jana Zielonka; Myra Nunez; Geoffrey Chupp; Martin D Slade; Lauren Cohn; Maor Sauler; Jose L Gomez; Robert Tarran; Lokesh Sharma; Charles S Dela Cruz; Marie Egan; Theresa Laguna; Clemente J Britto
Journal:  Eur Respir J       Date:  2021-11-11       Impact factor: 33.795

Review 4.  The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable Haemophilus influenzae.

Authors:  Yu-Ching Su; Farshid Jalalvand; John Thegerström; Kristian Riesbeck
Journal:  Front Immunol       Date:  2018-11-05       Impact factor: 7.561

Review 5.  Why new biology must be uncovered to advance therapeutic strategies for chronic obstructive pulmonary disease.

Authors:  Jennifer M K Nguyen; Douglas N Robinson; Venkataramana K Sidhaye
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-11-11       Impact factor: 5.464

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.